Search results Search for: Search Refine your results by duration: Any Under 5 mins Under 20 mins Over 20 mins Sort by: Relevance Views Date NantHealth: Payer Readiness for Autoimmune Biosimilars Dr. Tiffany Avery, CMO, NantHealth; Dr. Neha Bhanusali, Board certified in Rheumatology and Internal Medicine NantHealth explores the impact of new biosimilar drugs for autoimmune treatment. We will discuss how payers can prepare for the introduction of biosim... March 29, 2023 5:00pm A Hybrid Approach to Continuous Biomanufacturing of Biosimilars Andrew Falconbridge at Alvotech and Melisa Caprio at Repligen There has been an increasing trend in developing unit operations that can be utilised in a continuous fashion, although fully continuous end-to-end op... 2 months ago | 84 mins Platform tech development for biosimilar upscaling Dr Hung Fai Poon, President, QuaCell Biotech Ltd and Floris De Smet, Sartorius Stedim Biotech Discover strategies to move candidate molecules through development Building consistent, straightforward processes with low variability Exploring the ... 5 years ago | 68 mins Biosimilar Naming: How Could the Suffix Impact the U.S. Health System? Eric Henry, PharmD, Clinical Content Specialist with Clinical Effectiveness at Wolters Kluwer, Heath Join Eric Henry, Clinical Content Specialist focused on the domestic drug file with Clinical Effectiveness at Wolters Kluwer, Heath, in a 45-minute li... 4 years ago | 45 mins Fully continuous biosimilar manufacturing framework: A case study Samir Varma, Head of Manufacturing, Enzene Biosciences and Lotta Molander, Global Product Manager, GE Healthcare Biologics manufacturing has traditionally been in fed batch mode for the last 2 decades. During the early stages of biologics manufacturing, lower cel... 5 years ago | 68 mins Manufacturing strategies for Biosimilar: A case of continuous capture Solomon Alva, Biocon & Presented by Yvan Ruland, PhD, Technology Director, Asia/Pacific operations, Novasep Asia Presented By Solon Alva Antibody Purification Group Lead, Senior Scientific Manager, Biocon Research Limited Continuous manufacturing is an emerging ... 5 years ago | 74 mins Cost Considerations for the Application of Continuous Processing Narasimha Rao Nedunuri, CEO of CLONZ Biotech and Tania Pereira Chilima, Product Manager at Univercells Cost contribution of continuous manufacturing both in operational and capital expenditure in Monoclonal antibody production. Evaluating cost of produc... 3 years ago | 63 mins Cost Considerations for the Application of Continuous Processing Narasimha Rao Nedunuri, CEO of CLONZ Biotech and Tania Pereira Chilima, Product Manager at Univercells Cost contribution of continuous manufacturing both in operational and capital expenditure in Monoclonal antibody production. Evaluating cost of produc... 3 years ago | 62 mins Raw Material Lot Variability Challenges During Manufacturing of Biosimilars mab Sekhar Reddy, DSP Lead for Biosimilars at Biocon MSAT Downstream processing of Biosimilar Monoclonal Antibody utilises variety of raw materials that a critical for achieving the desired product quality. I... 4 years ago | 34 mins NIHR Clinical Research Network support for Biosimilars clinical trials Dr Sonya Abraham, Consultant Research Physician and Rheumatologist This presentation will discuss NIHR Clinical Research Network support for Biosimilar clinical trials. It begins with a background to biosimilars and t... 6 years ago | 16 mins
